The Prevalence of Obesity For Schizophrenia Inpatients in Taiwan
NCT01170689 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 710
Last updated 2010-07-28
Summary
This study is the first hospital-based, cross-sectional study to discuss the prevalence of obesity among 710 inpatients with schizophrenia.
Conditions
Sponsors & Collaborators
-
TsaoTun Psychiatric Center, Department of Health, Taiwan
lead OTHER
Principal Investigators
-
Ching Han-Yi, MD · Tsaotun Psychiatric Center
Eligibility
- Min Age
- 20 Years
- Max Age
- 72 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-03-31
- Primary Completion
- 2010-03-31
- Completion
- 2010-03-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Control of Metabolic and Cardiovascular Risk in Patients With Schizophrenia and Overweight
NCT00584519 ·Status: COMPLETED
-
A Neurobiological Study on Heterogeneity of Schizophrenia: Genetic Variations and Neurobiological Differentiations
NCT01075373 ·Status: UNKNOWN
-
Effects of Gene Polymorphisms on Metabolic Features in Clozapine-treated Patients With Schizophrenia
NCT01324167 ·Status: UNKNOWN
-
Therapeutic Effect of Cassia Seed in Obesity of Patients With Schizophrenia
NCT04252131 ·Status: COMPLETED ·Phase: PHASE1
-
Quetiapine Related Neurochemical Changes as Measured by Magnetic Resonance Spectroscopy in Schizophrenia
NCT00797927 ·Status: COMPLETED ·Phase: PHASE4
-
A Psychopathological Study of Latent (Early) Schizophrenia: Clinical Pathology/Neuropsychological Dysfunctions
NCT00155519 ·Status: COMPLETED
-
Biological Implications of the Overlapping Phenomenon Between Childhood Schizophrenia and Autism Spectrum Disorders-Heterogeneity Approach Rather Than Diagnostic Boundary
NCT06063525 ·Status: UNKNOWN
-
Prevalence of the Metabolic Syndrome in SPR Taking Antipsychotics
NCT00569504 ·Status: UNKNOWN
-
A Study on Psychopathological Progress of Early Schizophrenia-Like Disorder (SOPRES)
NCT00173069 ·Status: UNKNOWN
-
Neuroendocrine and Metabolite Substrates in Schizophrenia
NCT02423096 ·Status: UNKNOWN
-
Measurement of Activity Participation for Persons With Schizophrenia Living in the Community
NCT00172731 ·Status: COMPLETED
-
Investigation of Using Non-Wearable Devices to Assess Sleep- Disordered Breathing in Hospitalized Patients With Schizophrenia
NCT07192042 ·Status: RECRUITING
-
Effect of Dietary Fiber Supplement on the Intestinal Microbiota Among Schizophrenia Patients
NCT03552237 ·Status: UNKNOWN ·Phase: NA
-
Association of Multiple Genetic Polymorphisms With Clozapine-Associated Metabolic Change in Schizophrenia
NCT00717509 ·Status: UNKNOWN
-
Reducing the Weight of Overweight Schizophrenia Patients
NCT00158366 ·Status: COMPLETED ·Phase: NA
-
Theory Based Integrated Program on Medication Adherence Among Community Dwelling Schizophrenia
NCT05835583 ·Status: COMPLETED ·Phase: NA
-
Exploring Hand Function in People With Schizophrenia Based on Perspective of Sensorimotor Control
NCT04941677 ·Status: COMPLETED
-
Prevalence of Metabolic Syndrome in Patients With Schizophrenia in Korea
NCT01477918 ·Status: UNKNOWN
-
The Study of Atypical Antipsychotics-induced Metabolic Disturbances
NCT00937755 ·Status: COMPLETED
-
Genes Polymorphisms and Metabolic Effects of the Second Generation Antipsychotic Drugs in Patients With Schizophrenia
NCT02964923 ·Status: UNKNOWN
-
Feasibility and Preliminary Effect of Baduanjin Program for People Diagnosed With Schizophrenia
NCT04027634 ·Status: COMPLETED ·Phase: NA
-
Effect of Hot Footbath on the Sleep Quality
NCT04703530 ·Status: COMPLETED ·Phase: NA
-
Effects of Antipsychotics on Eating and Food Craving in People With Schizophrenia
NCT01222793 ·Status: COMPLETED
-
Risk Prediction Model of Cardiovascular Events in Patients With Schizophrenia
NCT05498571 ·Status: UNKNOWN
-
The Pharmacogenetic Study , Readiness to Change, and Pharmacological Intervention for Smoking Cessation in Schizophrenia
NCT00495352 ·Status: COMPLETED ·Phase: PHASE4